168 related articles for article (PubMed ID: 28832499)
21. Analysis of the binding modes of the first- and second-generation antiandrogens with respect to F876L mutation.
Shao G; Bao J; Pan X; He X; Qi Y; Zhang JZH
Chem Biol Drug Des; 2021 Jul; 98(1):60-72. PubMed ID: 33905591
[TBL] [Abstract][Full Text] [Related]
22. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
[TBL] [Abstract][Full Text] [Related]
23. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
Masiello D; Chen SY; Xu Y; Verhoeven MC; Choi E; Hollenberg AN; Balk SP
Mol Endocrinol; 2004 Oct; 18(10):2388-401. PubMed ID: 15256534
[TBL] [Abstract][Full Text] [Related]
24. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
25. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
[TBL] [Abstract][Full Text] [Related]
26. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
Ishikura N; Kawata H; Nishimoto A; Nakamura R; Tsunenari T; Watanabe M; Tachibana K; Shiraishi T; Yoshino H; Honma A; Emura T; Ohta M; Nakagawa T; Houjo T; Corey E; Vessella RL; Aoki Y; Sato H
Int J Oncol; 2015 Apr; 46(4):1560-72. PubMed ID: 25634071
[TBL] [Abstract][Full Text] [Related]
27. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
Marhefka CA; Moore BM; Bishop TC; Kirkovsky L; Mukherjee A; Dalton JT; Miller DD
J Med Chem; 2001 May; 44(11):1729-40. PubMed ID: 11356108
[TBL] [Abstract][Full Text] [Related]
28. The fluorescent two-hybrid assay for live-cell profiling of androgen receptor modulators.
Bogner J; Zolghadr K; Hickson I; Romer T; Yurlova L
J Steroid Biochem Mol Biol; 2017 Feb; 166():45-53. PubMed ID: 27174722
[TBL] [Abstract][Full Text] [Related]
29. Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking,
Selvaraj D; Muthu S; Kotha S; Siddamsetty RS; Andavar S; Jayaraman S
J Biomol Struct Dyn; 2021 Feb; 39(2):621-634. PubMed ID: 31928160
[TBL] [Abstract][Full Text] [Related]
30. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
[TBL] [Abstract][Full Text] [Related]
31. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens.
Terouanne B; Nirdé P; Rabenoelina F; Bourguet W; Sultan C; Auzou G
Mol Pharmacol; 2003 Apr; 63(4):791-8. PubMed ID: 12644579
[TBL] [Abstract][Full Text] [Related]
32. Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling.
Duan M; Liu N; Zhou W; Li D; Yang M; Hou T
J Chem Theory Comput; 2016 Sep; 12(9):4611-9. PubMed ID: 27560203
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
[TBL] [Abstract][Full Text] [Related]
35. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor.
Song LN; Coghlan M; Gelmann EP
Mol Endocrinol; 2004 Jan; 18(1):70-85. PubMed ID: 14593076
[TBL] [Abstract][Full Text] [Related]
36. The influence of the antiandrogen 2-hydroxyflutamide on the androgen receptor expression in the porcine ovarian follicles - an in vitro study.
Duda M; Wolna A; Knapczyk-Stwora K; Durlej-Grzesiak M; Knet M; Tabarowski Z; Slomczynska M
Reprod Domest Anim; 2013 Jun; 48(3):454-62. PubMed ID: 23113830
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Novel Anti-Resistance AR Antagonists Guided by Funnel Metadynamics Simulation.
Chen H; Zhou Y; Wang X; Chai X; Wang Z; Wang E; Xu L; Hou T; Li D; Duan M
Adv Sci (Weinh); 2024 May; 11(19):e2309261. PubMed ID: 38481034
[TBL] [Abstract][Full Text] [Related]
39. The discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedure.
Voet A; Helsen C; Zhang KY; Claessens F
ChemMedChem; 2013 Apr; 8(4):644-51. PubMed ID: 23436650
[TBL] [Abstract][Full Text] [Related]
40. Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions.
Chakraborty S; Kumar A; Butt NA; Zhang L; Williams R; Rimando AM; Biswas PK; Levenson AS
Mol Biosyst; 2016 May; 12(5):1702-9. PubMed ID: 27063447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
